Clear All
11120 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00069-4033-01 00069-4033 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Mar 5, 2013 Nov 30, 2020 In Use
25021-0207-25 25021-0207 Doxorubicin Hydrochloride doxorubicin hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct 31, 2013 Aug 31, 2020 No Longer Used
25021-0207-51 25021-0207 Doxorubicin Hydrochloride doxorubicin hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct 31, 2013 Sep 30, 2020 No Longer Used
25021-0242-02 25021-0242 Fludarabine phosphate Fludarabine phosphate 25.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Oct 15, 2016 In Use
25021-0245-01 25021-0245 Docetaxel Anhydrous Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Sep 15, 2017 In Use
25021-0778-66 25021-0778 Granisetron Hydrochloride Granisetron Hydrochloride 0.1 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous May 31, 2013 Jan 31, 2017 No Longer Used
60505-6228-00 60505-6228 Bendamustine Hydrochloride Bendamustine Hydrochloride 25.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Apr 26, 2023 In Use
55513-0956-01 55513-0956 Panitumumab Vectibix 400.0 mg/20mL Immunotherapy Monoclonal Antibody EGFR Intravenous Oct 10, 2006 In Use
00015-3215-30 00015-3215 Carboplatin Paraplatin Chemotherapy Alkylating Agent Platinum Compound Intravenous Jan 1, 2008 Apr 14, 2009 In Use
00015-3216-30 00015-3216 Carboplatin Paraplatin Chemotherapy Alkylating Agent Platinum Compound Intravenous Jan 1, 2006 Dec 31, 2007 In Use
00015-3556-26 00015-3556 Ifosfamide and Mesna Ifex and Mesnex Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jun 1, 2009 Jun 30, 2010 No Longer Used
53150-0314-01 53150-0314 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Apr 30, 2013 Dec 31, 2017 No Longer Used
00013-1176-87 00013-1176 Doxorubicin Hydrochloride Doxorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Dec 23, 1987 Jan 1, 2011 No Longer Used
66758-0045-01 66758-0045 Vinorelbine tartrate Vinorelbine tartrate 10.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous Feb 13, 2008 Oct 6, 2014 No Longer Used
00069-1542-20 00069-1542 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jul 22, 2024 In Use
69097-0905-67 69097-0905 Decitabine Decitabine 50.0 mg/10mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Sep 17, 2021 In Use
00143-9550-01 00143-9550 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan 2, 2018 In Use
00703-4094-01 00703-4094 Palonosetron Hydrochloride Palonosetron Hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Mar 23, 2018 In Use
71288-0112-90 71288-0112 Melphalan hydrochloride Melphalan hydrochloride Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jun 30, 2019 Apr 30, 2025 In Use
00703-4182-01 00703-4182 Vinorelbine Vinorelbine 10.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous Mar 1, 2003 Nov 30, 2012 No Longer Used
71288-0105-18 71288-0105 Levoleucovorin calcium Levoleucovorin 10.0 mg/mL Ancillary Therapy Chemoprotective Antidote Intravenous Aug 16, 2019 In Use
43066-0010-01 43066-0010 docetaxel Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Feb 19, 2018 In Use
47335-0581-40 47335-0581 Amifostine Amifostine 50.0 mg/mL Ancillary Therapy Chemoprotective Detoxifying Agent Intravenous Mar 14, 2008 Jul 31, 2013 No Longer Used
50242-0051-21 50242-0051 Rituximab Rituxan 10.0 mg/mL Immunotherapy Monoclonal Antibody CD20 Intravenous Nov 26, 1997 In Use
31722-0165-31 31722-0165 Fosaprepitant dimeglumine Fosaprepitant 150.0 mg/5mL Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Intravenous Jul 29, 2021 In Use

Found 11120 results — Export these results